Log in

NYSE:PRLBProto Labs Stock Price, Forecast & News

$77.21
-0.49 (-0.63 %)
(As of 04/10/2020 06:02 AM ET)
Add
Compare
Today's Range
$74.87
Now: $77.21
$79.25
50-Day Range
$64.61
MA: $79.70
$99.82
52-Week Range
$63.19
Now: $77.21
$119.98
Volume278,800 shs
Average Volume283,396 shs
Market Capitalization$2.07 billion
P/E Ratio32.86
Dividend YieldN/A
Beta1.55
Proto Labs, Inc., together with its subsidiaries, operates as an e-commerce driven digital manufacturer of custom parts for prototyping and short-run production worldwide. It utilizes injection molding, computer numerical control machining, three-dimensional (3D) printing, and sheet metal fabrication to manufacture custom parts for developers and engineers who use 3D computer-aided design software to design products across a range of end markets. The company was founded in 1999 and is headquartered in Maple Plain, Minnesota.
Read More
Proto Labs logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.01 out of 5 stars


Industry, Sector and Symbol

Industry Fabricated structural metal products
Sub-IndustryIndustrial Machinery
SectorIndustrial Products
CUSIP74371310
Phone763-479-3680

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$458.73 million
Cash Flow$3.62 per share
Book Value$21.89 per share

Profitability

Net Income$63.65 million

Miscellaneous

Employees2,535
Market Cap$2.07 billion
Next Earnings Date4/23/2020 (Estimated)
OptionableOptionable

Receive PRLB News and Ratings via Email

Sign-up to receive the latest news and ratings for PRLB and its competitors with MarketBeat's FREE daily newsletter.


Proto Labs (NYSE:PRLB) Frequently Asked Questions

How has Proto Labs' stock been impacted by COVID-19 (Coronavirus)?

Proto Labs' stock was trading at $78.36 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PRLB shares have decreased by 1.5% and is now trading at $77.21. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Proto Labs?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Proto Labs in the last year. There are currently 5 hold ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Proto Labs.

When is Proto Labs' next earnings date?

Proto Labs is scheduled to release its next quarterly earnings announcement on Thursday, April 23rd 2020. View our earnings forecast for Proto Labs.

How were Proto Labs' earnings last quarter?

Proto Labs Inc (NYSE:PRLB) announced its quarterly earnings results on Thursday, February, 6th. The industrial products company reported $0.63 earnings per share for the quarter, meeting analysts' consensus estimates of $0.63. The industrial products company earned $111.90 million during the quarter, compared to analysts' expectations of $111.95 million. Proto Labs had a return on equity of 11.31% and a net margin of 13.88%. The company's revenue for the quarter was down .8% on a year-over-year basis. During the same period in the previous year, the business posted $0.74 EPS. View Proto Labs' earnings history.

What guidance has Proto Labs issued on next quarter's earnings?

Proto Labs updated its first quarter earnings guidance on Thursday, February, 6th. The company provided EPS guidance of $0.50-0.58 for the period, compared to the Thomson Reuters consensus estimate of $0.67. The company issued revenue guidance of $111-117 million, compared to the consensus revenue estimate of $115.93 million.

What price target have analysts set for PRLB?

5 brokerages have issued 1-year target prices for Proto Labs' stock. Their forecasts range from $69.00 to $84.00. On average, they anticipate Proto Labs' share price to reach $76.50 in the next twelve months. This suggests that the stock has a possible downside of 0.9%. View analysts' price targets for Proto Labs.

Has Proto Labs been receiving favorable news coverage?

News headlines about PRLB stock have trended very negative this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Proto Labs earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave news stories about the industrial products company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the stock's share price in the immediate future. View the latest news aboutProto Labs.

Are investors shorting Proto Labs?

Proto Labs saw a increase in short interest during the month of March. As of March 13th, there was short interest totaling 3,973,500 shares, an increase of 7.1% from the February 27th total of 3,710,000 shares. Based on an average trading volume of 221,100 shares, the days-to-cover ratio is presently 18.0 days. Currently, 15.7% of the shares of the company are short sold. View Proto Labs' Current Options Chain.

Who are some of Proto Labs' key competitors?

What other stocks do shareholders of Proto Labs own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Proto Labs investors own include Brainstorm Cell Therapeutics (BCLI), Netflix (NFLX), Tesla (TSLA), NVIDIA (NVDA), Walt Disney (DIS), Starbucks (SBUX), Baidu (BIDU), Intel (INTC), Alphabet (GOOG) and Gilead Sciences (GILD).

Who are Proto Labs' key executives?

Proto Labs' management team includes the following people:
  • Ms. Victoria M. Holt, Pres, CEO & Director (Age 61)
  • Mr. John A. Way, CFO & Exec. VP of Devel. (Age 46)
  • Dr. Arthur Richard Baker III, Chief Technology Officer (Age 51)
  • Mr. David M. Fein, Chief Revenue Officer (Age 50)
  • Dan Schumacher, Director of Investor Relations and FP&A

What is Proto Labs' stock symbol?

Proto Labs trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRLB."

Who are Proto Labs' major shareholders?

Proto Labs' stock is owned by many different institutional and retail investors. Top institutional investors include State of Alaska Department of Revenue (0.09%). Company insiders that own Proto Labs stock include Arthur R Baker III, John B Goodman, John Way, Robert Bodor and Sven Wehrwein. View institutional ownership trends for Proto Labs.

Which institutional investors are buying Proto Labs stock?

PRLB stock was acquired by a variety of institutional investors in the last quarter, including State of Alaska Department of Revenue. View insider buying and selling activity for Proto Labs.

How do I buy shares of Proto Labs?

Shares of PRLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Proto Labs' stock price today?

One share of PRLB stock can currently be purchased for approximately $77.21.

How big of a company is Proto Labs?

Proto Labs has a market capitalization of $2.07 billion and generates $458.73 million in revenue each year. The industrial products company earns $63.65 million in net income (profit) each year or $2.35 on an earnings per share basis. Proto Labs employs 2,535 workers across the globe. View additional information about Proto Labs.

What is Proto Labs' official website?

The official website for Proto Labs is http://www.protolabs.com/.

How can I contact Proto Labs?

Proto Labs' mailing address is 5540 Pioneer Creek Drive, Maple Plain MN, 55359. The industrial products company can be reached via phone at 763-479-3680 or via email at [email protected]

This page was last updated on 4/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel